Zydus Lifesciences Limited (BOM:532321)

Zydus Lifesciences Revenue

Zydus Lifesciences had revenue of 80.17B INR in the quarter ending June 30, 2026, with 21.96% growth. This brings the company's total for the last twelve months to 285.92B, up 21.11% year-over-year. In the fiscal year ending March 31, 2026, Zydus Lifesciences had annual revenue of 271.48B with 16.81% growth.

• Revenue (ttm): 285.92B
• Revenue Growth: +21.11%
• P/S Ratio: 4.10
• Revenue / Employee: 9.54M
• Employees: 29,980
• Market Cap: 1.17T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceuticals (excl. Medical Technologies) 224.12B 82.6%
• Consumer Products 39.54B 14.6%
• Medical Technologies 7.82B 2.9%

By Geography

Chart

• United States 117.17B 43.2%
• India 97.18B 35.8%
• Others 30.38B 11.2%
• Europe 26.75B 9.9%

Fiscal year ended Mar 31, 2026 See the full Zydus Lifesciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	271.48B	39.07B	16.81%
Mar 31, 2025	232.42B	36.94B	18.90%
Mar 31, 2024	195.47B	23.10B	13.40%
Mar 31, 2023	172.37B	21.28B	14.08%
Mar 31, 2022	151.10B	7.06B	4.90%

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error